Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcv.2020.104682 http://scihub22266oqcxt.onion/10.1016/j.jcv.2020.104682 33152666!7598902!33152666     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Virol 2020 ; 133 (ä): 104682 Nephropedia Template TP {{tp|p=33152666|t=2020. Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19 |pdf=|usr=}}{{33152666}} gab.com Text Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19 JO: J Clin Virol http://www.kidney.de/pget.php?&tw=1&pmid=33152666 #FOAvip BACKGROUND: With the persistent COVID-19 pandemic, there is an urgent need to use rapid and reliable diagnostic tools for highly urgent cases. Antigen tests are disappointing with their lack of sensitivity. Among molecular tools allowing a diagnosis in less than an hour, only one, the Cepheid Xpert Xpress SARS-CoV-2 assay, has exhibited a good sensitivity. However, we are also facing a global shortage of reagents and kits. Thus, it is imperative to evaluate other point-of-care molecular tests. METHODS: We evaluated the VitaPCR RT-PCR assay, whose sample analysis time is of approximately 20 min, in nasopharyngeal secretions from 534 patients presenting to our Institute, for the diagnosis of COVID-19, and compared it to our routine RT-PCR assay. We also compared the two assays with tenfold dilutions of a SARS-CoV-2 strain. RESULTS: Compared to our routine RT-PCR and the previous diagnosis of COVID-19, the sensitivity, specificity, positive and negative predictive values of VitaPCR can be evaluated to be 99.3 % (155/156), 94.7 % (358/378), 88.6 % (155/175) and 99.7 % (358/359), respectively. Tenfold dilutions of a SARS-CoV-2 strain show that the VitaPCR was more sensitive that our routine RT-PCR assay. CONCLUSION: The VitaPCR SARS-CoV-2 is an accurate rapid test, suitable for clinical practice that can be performed as part of a point-of-care testing, for the rapid diagnosis of COVID-19. Twit Text FOAVip Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19 ????J Clin Virol http://www.kidney.de/pget.php?&tw=1&pmid=33152666 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33152666 #FOAvip English Wikipedia <ref>{{Cite pmid|33152666}}</ref> Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19 #MMPMID33152666 Fournier PE; Zandotti C; Ninove L; Prudent E; Colson P; Gazin C; Million M; Tissot-Dupont H; Fenollar F J Clin Virol 2020[Dec]; 133 (ä): 104682 PMID33152666show ga BACKGROUND: With the persistent COVID-19 pandemic, there is an urgent need to use rapid and reliable diagnostic tools for highly urgent cases. Antigen tests are disappointing with their lack of sensitivity. Among molecular tools allowing a diagnosis in less than an hour, only one, the Cepheid Xpert Xpress SARS-CoV-2 assay, has exhibited a good sensitivity. However, we are also facing a global shortage of reagents and kits. Thus, it is imperative to evaluate other point-of-care molecular tests. METHODS: We evaluated the VitaPCR RT-PCR assay, whose sample analysis time is of approximately 20 min, in nasopharyngeal secretions from 534 patients presenting to our Institute, for the diagnosis of COVID-19, and compared it to our routine RT-PCR assay. We also compared the two assays with tenfold dilutions of a SARS-CoV-2 strain. RESULTS: Compared to our routine RT-PCR and the previous diagnosis of COVID-19, the sensitivity, specificity, positive and negative predictive values of VitaPCR can be evaluated to be 99.3 % (155/156), 94.7 % (358/378), 88.6 % (155/175) and 99.7 % (358/359), respectively. Tenfold dilutions of a SARS-CoV-2 strain show that the VitaPCR was more sensitive that our routine RT-PCR assay. CONCLUSION: The VitaPCR SARS-CoV-2 is an accurate rapid test, suitable for clinical practice that can be performed as part of a point-of-care testing, for the rapid diagnosis of COVID-19. |*COVID-19 Nucleic Acid Testing[MESH] |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*diagnosis[MESH] |Emergency Medical Services[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Nasopharynx/*virology[MESH] |Point-of-Care Testing[MESH] |Predictive Value of Tests[MESH] |SARS-CoV-2/genetics[MESH] |Sensitivity and Specificity[MESH] |Time Factors[MESH]Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID(epmc).pdf DeepDyve Pubget Overpricing